Neurons predicts attention. Videoquant predicts which ad wins — before you spend a dollar.
Unlimited predictions and scene-level diagnostics — starting at $6K/mo.
Request a Proof of ConceptNeurons uses AI trained on eye-tracking and neuroscience data to predict where people will look and what they'll remember. That's valuable — attention is a prerequisite for any ad to work. But attention doesn't tell you which ad wins in market.
Videoquant is trained on 18 trillion real-world outcomes — when two pieces of content competed for engagement in the real world, which one won? We learn from what actually worked in market, not just what caught someone's eye. Our scoring engine then breaks down predicted performance at the scene, utterance, and copy level — so you know exactly what's driving results.
We proved with Fortune 500 & Super Bowl advertisers that this beats all other approaches to predicting real-world outcomes, and were awarded a patent on it.
Neurons predicts where people will look, how much cognitive effort your ad requires, and what they'll remember. Useful for design and layout decisions. But an ad can score perfectly on attention and still fail to drive action.
Videoquant predicts which ad wins, provides diagnostics on what's working and what isn't, and lets you get scene, utterance, and copy-level diagnostics from — trained on real behavioral data from 200M+ adults. Ask why one concept resonates more than another. Explore messaging angles. Pressure-test a CTA. All in under 20 seconds.
Neurons tells you where people look. Videoquant tells you which ad wins, why, and for whom. Attention is one input — real-world competitive outcomes are the scoreboard.
Neurons charges ~$16,000/year for 5 seats. Videoquant starts at $6K/mo for unlimited testing across your entire team — every concept, brief, and cut. No seat limits. No volume caps.
Neurons models general human attention patterns. Videoquant builds LLMs that learn how your specific target audience behaves — sports bettors, luxury shoppers, competitor viewers — trained on real behavioral data from 200M+ adults. You can see exactly which scenes, utterances, and copy elements are predicted to work or not.
Score creative and get diagnostics faster than Neurons generates an attention heatmap. Test during the meeting, not after.
Videoquant doesn't just give you a score. It breaks down predicted performance at the scene, utterance, and copy level — so you know which specific elements are driving or hurting results. Then it identifies alternative copy and concepts with higher predicted performance.
Ask My Audience lets you interact with an AI model of your target audience and ask how they'd respond to concepts, CTAs, taglines, and messaging angles — based on real behavioral data. It's a brainstorming and concept exploration tool, separate from ad scoring and diagnostics.
Predictions validated across TV, paid social, app store, and offer testing by publicly traded brands spending billions on marketing.
All phases: concept to finished cut, across TV, social, app store, OOH, and more.
Both use AI, but they predict different things. Neurons predicts attention — where people look, cognitive load, memory encoding — based on eye-tracking research. Videoquant predicts which ad wins in market based on 18 trillion real-world competitive outcomes, provides diagnostics, and lets you get scene, utterance, and copy-level diagnostics from. Attention is one factor in ad performance; Videoquant predicts the outcome. Neurons requires ~$16K/year. Videoquant starts at $6K/mo for unlimited testing.
For different questions. Neurons is validated for predicting visual attention. Videoquant is validated for predicting which ad wins in market — with results like 4.1x acquisition improvement and 81% lower acquisition cost in controlled tests (p < 0.001) with Fortune 500 & Super Bowl advertisers. We were awarded a U.S. patent for proving our methodology beats other approaches.
Neurons provides attention heatmaps and cognitive load scores — useful for design decisions. Videoquant provides predictions and scene, utterance, and copy-level diagnostics — so you know exactly which elements are driving or hurting performance. Then it identifies alternative copy and concepts with higher predicted performance. Separately, Ask My Audience lets you brainstorm with an AI model of your audience — but the diagnostic layer is baked into the scoring, not a conversation.
Ask My Audience is an AI model trained on behavioral data from 200M+ adults and 18T+ real-world outcomes. It learns how specific audience segments actually behave. You can ask it questions in plain language — "How would this audience respond to a discount-first message vs. a quality-first message?" or "What messaging angles resonate most with competitor viewers?" — and get answers informed by real behavior. It's a brainstorming and concept exploration tool, separate from ad scoring. For diagnostics on specific creative assets, Videoquant's scoring engine breaks performance down at the scene, utterance, and copy level.
For ad creative testing, yes. Both platforms evaluate TV ads, digital video, social ads, and static images. Neurons also offers UX/website testing and Figma integration, which Videoquant does not. Videoquant is built specifically for advertising performance prediction with custom audiences.
Neurons offers unlimited tests within their annual subscription, which works well for teams testing daily. Videoquant also offers unlimited testing starting at $6K/mo — with the added capability of custom AI audiences, diagnostics, and audience Q&A. We also offer a proof of concept before any commitment.
Videoquant starts at $6K/mo. We offer a proof of concept first — we'll score your ads and show you what our model would have predicted. No data needed. No cost. If predictions don't hold up, you don't move forward.
We'll score your ads and show you what our model would have predicted. No data needed. No cost.
Request a Proof of Concept